Asian Journal Of Social Pharmacy

Abstract: Objective To explore the concept of expert conflicts of interest in drug evaluation process and the necessity to manage conflicts of interest, and to propose suggestions for regulating expert conflicts of interest in China by learning from experience of drug regulatory authorities in foreign countries. Methods Comparative method was used to study the management of expert conflicts of interest in drug evaluation process in Europe, the United States and China. Results and Conclusion FDA and EU attach great importance to the role of experts in drug evaluation process, and they also cope with the problems of expert conflicts of interest successfully. In contrast, there are some problems in drug evaluation process in China. Therefore, it is necessary to strengthen the transparency of evaluation process to avoid expert conflicts of interest and ensure the impartiality and scientific nature of their opinions.

Key words: American, EU, drug evaluation, expert, conflict of interest